Granard Pharmaceuticals

Granard Pharmaceuticals is a privately held specialty pharmaceutical company based in Cary, North Carolina, focused on the development and commercialization of niche generic and branded drug products. The company targets underserved therapeutic areas where it can provide high-quality, cost-effective alternatives to existing medications. Their portfolio primarily consists of small molecule therapeutics in oral and topical dosage forms, covering indications such as pain management, central nervous system disorders, and respiratory conditions. Granard utilizes a strategic partnership model for manufacturing and distribution, allowing for a lean and efficient operational structure. The company is committed to expanding its product pipeline through internal development and strategic acquisitions of Abbreviated New Drug Applications (ANDAs).